{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:32:41Z","timestamp":1779265961963,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03809-y","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:17:43Z","timestamp":1745252263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative outcomes of laparoscopic and open gastrectomy for T4b gastric cancer with transverse colon or mesentery invasion: a dual-center retrospective analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Yi-ming","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-kuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-hui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-xin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-juan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"3","key":"3809_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3809_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11605-018-3746-5","volume":"23","author":"JC Molina","year":"2019","unstructured":"Molina JC, Al-Hinai A, Gosseling-Tardif A, et al. Multivisceral resection for locally advanced gastric and gastroesophageal junction cancers\u201411-year experience at a high-volume North American center. J Gastrointest Surg. 2019;23(1):43\u201350.","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"3809_CR3","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1007\/s00268-005-0582-z","volume":"30","author":"C Kunisaki","year":"2006","unstructured":"Kunisaki C, Makino H, Takagawa R, et al. Surgical outcomes in patients with T4 gastric carcinoma invading adjacent organs. World J Surg. 2006;30(10):1864\u201370.","journal-title":"World J Surg"},{"issue":"6","key":"3809_CR4","first-page":"1011","volume":"23","author":"MA Sahakyan","year":"2020","unstructured":"Sahakyan MA, Melkonyan AL, Sargsyan L, et al. Extended gastrectomy for T4b gastric adenocarcinoma with adjacent organ invasion. Gastric Cancer. 2020;23(6):1011\u201321.","journal-title":"Gastric Cancer"},{"issue":"20","key":"3809_CR5","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1001\/jama.2019.5359","volume":"321","author":"J Yu","year":"2019","unstructured":"Yu J, Huang C, Sun Y, et al. Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321(20):1983\u201392. https:\/\/doi.org\/10.1001\/jama.2019.5359","journal-title":"JAMA"},{"issue":"28","key":"3809_CR6","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1200\/JCO.20.01210","volume":"38","author":"WJ Hyung","year":"2020","unstructured":"Hyung WJ, Yang HK, Park YK, et al. Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol. 2020;38(28):3304\u201313. https:\/\/doi.org\/10.1200\/JCO.20.01210","journal-title":"J Clin Oncol"},{"issue":"3","key":"3809_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.12669\/pjms.292.2898","volume":"29","author":"L Xiao","year":"2013","unstructured":"Xiao L, Li M, Xu F, et al. Extended multi-organ resection for cT4 gastric carcinoma: a retrospective analysis. Pak J Med Sci. 2013;29(3):581\u20135. https:\/\/doi.org\/10.12669\/pjms.292.2898","journal-title":"Pak J Med Sci"},{"issue":"1","key":"3809_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12029-019-00222-z","volume":"51","author":"MA Sahakyan","year":"2020","unstructured":"Sahakyan MA, Gabrielyan A, Petrosyan H, et al. Extended gastrectomy for T4b gastric adenocarcinoma: single-surgeon experience. J Gastrointest Cancer. 2020;51(1):135\u201343. https:\/\/doi.org\/10.1007\/s12029-019-00222-z","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"3809_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","volume":"26","author":"Japanese Gastric Cancer Association","year":"2023","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1\u201325. https:\/\/doi.org\/10.1007\/s10120-022-01331-8","journal-title":"Gastric Cancer"},{"issue":"6","key":"3809_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S1072-7515(03)00126-1","volume":"196","author":"DM D\u2019Ugo","year":"2003","unstructured":"D\u2019Ugo DM, Pende V, Persiani R, Rausei S, Picciocchi A. Laparoscopic staging of gastric cancer: an overview. J Am Coll Surg. 2003;196(6):965\u201374. https:\/\/doi.org\/10.1016\/S1072-7515(03)00126-1","journal-title":"J Am Coll Surg"},{"issue":"2","key":"3809_CR11","first-page":"189","volume":"18","author":"V Muntean","year":"2009","unstructured":"Muntean V, Mihailov A, Iancu C, et al. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointestin Liver Dis. 2009;18(2):189\u201395.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"3","key":"3809_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0002-9610(00)00293-2","volume":"179","author":"Y Kasakura","year":"2000","unstructured":"Kasakura Y, Fujii M, Mochizuki F, Kochi M, Kaiga T. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg. 2000;179(3):237\u201342. https:\/\/doi.org\/10.1016\/s0002-9610(00)00293-2","journal-title":"Am J Surg"},{"issue":"1","key":"3809_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.amjsurg.2008.06.031","volume":"198","author":"I Ozer","year":"2009","unstructured":"Ozer I, Bostanci EB, Orug T, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198(1):25\u201330. https:\/\/doi.org\/10.1016\/j.amjsurg.2008.06.031","journal-title":"Am J Surg"},{"issue":"9","key":"3809_CR14","first-page":"3578","volume":"27","author":"W Wang","year":"2020","unstructured":"Wang W, Zhang Z, Wang Y, et al. Surgical outcomes and survival for T4 gastric cancer patients with multivisceral resection. Ann Surg Oncol. 2020;27(9):3578\u201385.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3809_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10120-017-0701-1","volume":"21","author":"T Fukagawa","year":"2018","unstructured":"Fukagawa T, Katai H, Mizusawa J, et al. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A). Gastric Cancer. 2018;21(1):68\u201373. https:\/\/doi.org\/10.1007\/s10120-017-0701-1","journal-title":"Gastric Cancer"},{"issue":"6","key":"3809_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1445-2197.2006.03751.x","volume":"76","author":"DY Kim","year":"2006","unstructured":"Kim DY, Joo JK, Seo KW, et al. T4 gastric carcinoma: the benefit of non-curative resection. ANZ J Surg. 2006;76(6):453\u20137. https:\/\/doi.org\/10.1111\/j.1445-2197.2006.03751.x","journal-title":"ANZ J Surg"},{"issue":"2","key":"3809_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.12669\/pjms.292.2898","volume":"29","author":"L Xiao","year":"2013","unstructured":"Xiao L, Li M, Xu F, et al. Extended multi-organ resection for cT4 gastric carcinoma: a retrospective analysis. Pak J Med Sci. 2013;29(2):581\u20135. https:\/\/doi.org\/10.12669\/pjms.292.2898","journal-title":"Pak J Med Sci"},{"issue":"6","key":"3809_CR18","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1245\/s10434-010-1534-x","volume":"18","author":"CT Cheng","year":"2011","unstructured":"Cheng CT, Tsai CY, Hsu JT, et al. Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth?? Ann Surg Oncol. 2011;18(6):1606\u201314. https:\/\/doi.org\/10.1245\/s10434-010-1534-x","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3809_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11605-020-04719-y","volume":"25","author":"JG Aversa","year":"2021","unstructured":"Aversa JG, Diggs LP, Hagerty BL, et al. Multivisceral resection for locally advanced gastric cancer. J Gastrointest Surg. 2021;25(3):609\u201322. https:\/\/doi.org\/10.1007\/s11605-020-04719-y","journal-title":"J Gastrointest Surg"},{"issue":"23","key":"3809_CR20","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.3390\/jcm12237360","volume":"12","author":"D Schizas","year":"2023","unstructured":"Schizas D, Giannakodimos I, Mylonas KS, et al. Multivisceral resection for locally advanced gastric cancer: a systematic review and evidence quality assessment. J Clin Med. 2023;12(23):7360. https:\/\/doi.org\/10.3390\/jcm12237360. Published 2023 Nov 28.","journal-title":"J Clin Med"},{"issue":"1","key":"3809_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa055531","journal-title":"N Engl J Med"},{"issue":"13","key":"3809_CR22","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321. https:\/\/doi.org\/10.1200\/JCO.2010.33.0597","journal-title":"J Clin Oncol"},{"issue":"12","key":"3809_CR23","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"SE Al-Batran","year":"2016","unstructured":"Al-Batran SE, Hofheinz RD, Pauligk C, et al. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2\/3 trial. Lancet Oncol. 2016;17(12):1697\u2013708. https:\/\/doi.org\/10.1016\/S1470-2045(16)30531-9","journal-title":"Lancet Oncol"},{"issue":"2","key":"3809_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10120-020-01136-7","volume":"24","author":"Y Iwasaki","year":"2021","unstructured":"Iwasaki Y, Terashima M, Mizusawa J, et al. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial[J]. Gastric Cancer. 2021;24(2):492\u2013502. https:\/\/doi.org\/10.1007\/s10120-020-01136-7","journal-title":"Gastric Cancer"},{"key":"3809_CR25","doi-asserted-by":"publisher","unstructured":"Li C, Tian Y, Zheng Y, et al. Pathologic response of phase III study: perioperative camrelizumab plus rivoceranib and chemotherapy versus chemotherapy for locally advanced gastric cancer (DRAGON IV\/CAP 05). J clin oncol. Published Online Oct. 2024;9. https:\/\/doi.org\/10.1200\/JCO.24.00795","DOI":"10.1200\/JCO.24.00795"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03809-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03809-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03809-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:17:44Z","timestamp":1745252264000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03809-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3809"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03809-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the Cancer Hospital, Chinese Academy of Medical Sciences (22\/274\u20133476).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Prior to surgery, all patients and their families provided informed consent, acknowledging and consenting to the potential use of clinical data collected during their treatment for future research. Therefore, when using retrospectively collected patient data, informed consent can be waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}